Wellness
Plasmid Manufacturing Strategies for Diverse Therapeutic Candidates
In this GEN webinar, sponsored by ProBio, our distinguished speaker, Dr. Ming Ni, will discuss GenScript ProBio’s plasmid platform technologies designed…
Broadcast Date: March 10, 2023
Time: 8:00 am PT, 11:00 am ET, 17:00 CET
The value of plasmid DNA in today’s biopharma industry cannot be overstated. Plasmid ubiquity can be seen in many therapeutic areas as they are widely used in cell and gene therapy, serve as raw materials for viral vector production and act as the delivery vehicle to transfer the gene of interest or the final drug product in the case of DNA vaccine. Yet, often manufacturing these vectors at scale can present challenges for organizations looking to focus their efforts on therapeutic outcomes rather than bioprocessing roadblocks. Thankfully, solutions abound.
In this GEN webinar, our distinguished speaker, Dr. Ming Ni, will discuss GenScript ProBio’s plasmid platform technologies designed for producing plasmid DNA in high yields using advanced methodologies. In addition, Dr. Ni will describe the GenScript teams’ capabilities for providing CDMO services from the preclinical plasmid preparation, through the IND application, to commercial products.
A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelist.
Produced with support from:
Principal Project Manager
GenScript ProBio
The post Plasmid Manufacturing Strategies for Diverse Therapeutic Candidates appeared first on GEN – Genetic Engineering and Biotechnology News.
Lion’s Mane Mushroom: History, Benefits, and Adaptogen Properties
Explore the intriguing world of Lion’s Mane Mushroom in our comprehensive guide. Dive into its unique properties, historical significance, and myriad health…
AI can already diagnose depression better than a doctor and tell you which treatment is best
Artificial intelligence (AI) shows great promise in revolutionizing the diagnosis and treatment of depression, offering more accurate diagnoses and predicting…
Reasons You should Get this: Neptune Wellness Solutions Inc (NASDAQ:NEPT), WeTrade Group Inc. (NASDAQ:WETG)
NEPT has seen its SMA50 which is now -9.28%. In looking the SMA 200 we see that the stock has seen a -92.25%. WETG has seen its SMA50 which is …
The…
